Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

FUE technique can effectively create natural-looking eyebrow transplants.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Curly hair in certain scalp areas can be an early sign of hair loss.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Camellia seed cake extract may help hair growth by blocking the hair loss effects of a hormone called DHT.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Hormones, especially androgens, affect hair growth and can cause hair loss or excess hair in both men and women.

Few people stick with topical minoxidil due to side effects, so alternatives and strategies are needed.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Androgen and Wnt signals are crucial for developing and functioning male genitalia and erectile tissues.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Early diagnosis and treatment are crucial for managing female hair loss effectively.

Post-COVID-19 hair loss can be treated effectively with therapies like light therapy, microneedling, and scalp massage.

Two women with darker skin had both frontal hair thinning and skin discoloration.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.